Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quote from Keytruda.com

<< Previous

Bullboard Posts

Next >>

Comment by Gman620on Jan 25, 2024 11:41am

141 Views

Post# 35845105

RE:RE:Quote from Keytruda.com

They have a standalone trial/treatment and one with Keytruda. There is large inventory of Keytruda that needs to be used. The combo treatment has high CR. We aren't talking at all about Keytruda alone. We all know about that.

My interests are to see TLT succeed and for there to be a high CR treatment. I didn't invest in CG but good luck to them. I just see it as an overall negative for TLT, and perhaps quickly moving to another cancer to attack, if TLT can find the money would be wise.

I'm sorry about your friends. That is horrible.

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition